economy
January 23, 2026
Novartis CEO: Confident we are shielded from any further U.S. tariffs
Novartis CEO Vas Narasimhan told CNBC in Davos that he believes the Swiss drugmaker is protected from any additional U.S. tariffs on Europe, citing its U.S. manufacturing footprint, inventory levels, and an existing agreement with the Trump administration. He also warned that Europe risks reaching a crisis point unless it ramps up investment into its own innovation and R&D.
TL;DR
- Novartis CEO Vas Narasimhan believes the company is protected from potential U.S. tariffs on Europe.
- Reasons for protection include U.S. manufacturing, inventory levels, and an existing agreement with the Trump administration.
- Narasimhan warned Europe risks a crisis if it does not increase investment in innovation and R&D.
Continue reading the original article